Does meclizine cause dizziness, and why is it prescribed for dizziness?

Does Meclizine Cause Dizziness?

Yes, meclizine can cause dizziness as a side effect, but it is prescribed to treat vertigo (a specific type of dizziness) by suppressing vestibular signals and reducing nausea associated with motion sickness.

Understanding the Paradox

Meclizine is an antihistamine with anticholinergic properties that works by:

• Suppressing the central emetic center to relieve nausea and vomiting associated with motion sickness 1
• Reducing vestibular signals that cause the spinning sensation of vertigo
• Blocking histamine receptors in the inner ear and brain

However, this same mechanism can produce drowsiness and dizziness as adverse effects 2.

FDA-Approved Indication

According to the FDA drug label, meclizine is indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults 2. The recommended dosage is 25 mg to 100 mg daily in divided doses 2.

Critical Clinical Caveat: When NOT to Use Meclizine

Meclizine should NOT be routinely prescribed for benign paroxysmal positional vertigo (BPPV), the most common cause of vertigo 1, 3. The American Academy of Otolaryngology-Head and Neck Surgery guidelines explicitly recommend against routine use of vestibular suppressants like meclizine for BPPV, with only limited exceptions 1, 3.

Why This Matters:

• BPPV is best treated with repositioning maneuvers (Epley maneuver), which have 4.1 times greater symptom resolution rates than control groups 1
• Meclizine provides no definitive treatment for BPPV and only masks symptoms temporarily 1, 3
• Vestibular suppressants interfere with central compensation in peripheral vestibular conditions 1

Limited Acceptable Uses for BPPV:

Meclizine may be considered only for 3:

• Short-term management of severe nausea/vomiting in severely symptomatic patients
• Prophylaxis before canalith repositioning procedures in patients with previous severe nausea
• Patients refusing other treatment options (not ideal, but pragmatic)

Maximum duration: 3 days 4

Significant Safety Concerns

Fall Risk - The Most Important Harm

Recent high-quality evidence shows meclizine use is associated with substantially increased fall risk 5:

• Among 805,454 adults with dizziness, those prescribed meclizine had:
  • 2.94 times higher fall risk in patients aged 18-64 years
  • 2.54 times higher fall risk in patients aged ≥65 years
• Falls occurred within 60 days of meclizine prescription
• This association persisted even after adjusting for clinical factors

In older adults with vestibular disorders who sustained hip fractures, 38.3% had been prescribed meclizine, including 29.9% before the fracture 6. Notably, 66.7% of patients with BPPV received meclizine despite guideline recommendations against this practice 6.

Other Adverse Effects

The FDA label lists 2:

• Drowsiness (most common - requires warning about driving/machinery)
• Dry mouth
• Headache
• Fatigue
• Blurred vision (rare)
• Anaphylactic reaction (rare)

Additional concerns from guidelines 7, 8:

• Orthostatic hypotension
• Cognitive impairment
• Urinary retention (anticholinergic effect)
• Increased fall risk (independent risk factor)

High-Risk Populations

Use with caution in 2:

• Asthma
• Glaucoma
• Prostate enlargement
• Elderly patients (higher fall risk)

When Meclizine IS Appropriate

Meclizine has legitimate uses for:

1. Ménière's Disease: For symptomatic management of vertigo attacks only during acute episodes 9
2. Other vestibular disorders (not BPPV): For short-term symptom control (≤3 days) 4
3. Motion sickness prevention: Though this is a different indication than vertigo treatment

Clinical Algorithm for Vertigo Management

Step 1: Diagnose the cause

• Perform Dix-Hallpike test if BPPV suspected 10
• If positive → BPPV (do NOT prescribe meclizine routinely)
• If negative → consider other vestibular causes

Step 2: For BPPV (most common)

• First-line: Epley maneuver (canalith repositioning) 3, 10
• Reassess within 1 month 1
• Meclizine only if severe nausea/vomiting AND patient refuses maneuver

Step 3: For other vestibular disorders

• Consider meclizine for acute symptom control only (maximum 3 days) 4
• Address underlying cause
• Refer for vestibular rehabilitation if symptoms persist

Step 4: Patient education

• Warn about drowsiness and fall risk 2
• Avoid alcohol and CNS depressants 2
• Avoid driving/operating machinery 2

Drug Interactions

• CNS depressants (including alcohol): Increased sedation 2
• CYP2D6 inhibitors: May increase meclizine levels; monitor for adverse effects 2

Bottom Line for Clinical Practice

Meclizine causes dizziness/drowsiness as a side effect but treats vertigo by suppressing vestibular signals. However, its use should be highly selective and time-limited. The most common mistake is prescribing meclizine for BPPV when repositioning maneuvers are far more effective and avoid medication-related harms, particularly falls. The recent evidence linking meclizine to increased fall risk in both younger and older adults should make clinicians reconsider routine prescribing practices 5. When meclizine is used, limit to 3 days maximum and counsel extensively about fall prevention strategies.